TGFB1 and liver disorder: Increasing evidence shows that TGF-β1 is a key mediator in the pathogenesis of liver fibrosis in both experimental and human liver diseases: TGF-β1 is highly upregulated in the form of either the transcript or protein in the fibrotic tissues of animal models or human samples [41,42].